Top section
Top section
High yields and tight senior/sub spread fuel enthusiasm for issuance among investors and issuers
◆ Pair help market to end week on a high note ◆ GSK offers pick-up over peer AstraZeneca ◆ Glencore finds demand at eight years
◆ French borrower takes €1.15bn across two tranches ◆ Balance struck between size and price to keep investors onside ◆ Small concession offered
Data
More articles
More articles
More articles
-
-
◆ Brewer taps 'sweetest spot' for duration ◆ Sharper tightening on one tranche than the other ◆ World Cup is expected to support sales volumes for the issuer
-
◆ LVMH draws heavy demand despite share price slide ◆ Longer tranche takes bigger bite of interest ◆ Both lines land with slim concessions
-
This week's flurry of deals takes year to date volume beyond £8bn
-
The AI race is pushing hyperscalers to hunt for cash to fund rising capex needs, and they are coming to Switzerland
-
Tech giant's meditation on permanence offered investors a juicy a pick-up for taking just a little more duration risk
Sub-sections